12-102958393-CGCAGCAGCAGCAGCAGCAGCAGCAGCA-CGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_004316.4(ASCL1):​c.178_186dupCAGCAGCAG​(p.Gln60_Gln62dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 129 hom., cov: 0)
Exomes 𝑓: 0.017 ( 65 hom. )

Consequence

ASCL1
NM_004316.4 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.219

Publications

15 publications found
Variant links:
Genes affected
ASCL1 (HGNC:738): (achaete-scute family bHLH transcription factor 1) This gene encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors. The protein activates transcription by binding to the E box (5'-CANNTG-3'). Dimerization with other BHLH proteins is required for efficient DNA binding. This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons. Mutations in this gene may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases. [provided by RefSeq, Jul 2008]
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]
PAH Gene-Disease associations (from GenCC):
  • phenylketonuria
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
  • classic phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • maternal phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild hyperphenylalaninemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 12-102958393-C-CGCAGCAGCA is Benign according to our data. Variant chr12-102958393-C-CGCAGCAGCA is described in ClinVar as [Benign]. Clinvar id is 162757.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASCL1NM_004316.4 linkc.178_186dupCAGCAGCAG p.Gln60_Gln62dup conservative_inframe_insertion Exon 1 of 2 ENST00000266744.4 NP_004307.2 P50553
PAHNM_001354304.2 linkc.-303_-295dupTGCTGCTGC 5_prime_UTR_variant Exon 1 of 14 NP_001341233.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASCL1ENST00000266744.4 linkc.178_186dupCAGCAGCAG p.Gln60_Gln62dup conservative_inframe_insertion Exon 1 of 2 1 NM_004316.4 ENSP00000266744.3 P50553
PAHENST00000547319.1 linkn.9_17dupTGCTGCTGC non_coding_transcript_exon_variant Exon 1 of 3 4
PAHENST00000551337.5 linkc.-303_-295dupTGCTGCTGC upstream_gene_variant 3 ENSP00000447620.1 F8W0A0
PAHENST00000635500.1 linkn.-180_-172dupTGCTGCTGC upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0286
AC:
4297
AN:
150084
Hom.:
129
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0223
Gnomad ASJ
AF:
0.0237
Gnomad EAS
AF:
0.170
Gnomad SAS
AF:
0.0483
Gnomad FIN
AF:
0.00295
Gnomad MID
AF:
0.00962
Gnomad NFE
AF:
0.00919
Gnomad OTH
AF:
0.0302
GnomAD4 exome
AF:
0.0166
AC:
22475
AN:
1356546
Hom.:
65
Cov.:
17
AF XY:
0.0171
AC XY:
11411
AN XY:
669058
show subpopulations
African (AFR)
AF:
0.0518
AC:
1475
AN:
28476
American (AMR)
AF:
0.0243
AC:
818
AN:
33674
Ashkenazi Jewish (ASJ)
AF:
0.0281
AC:
674
AN:
24000
East Asian (EAS)
AF:
0.168
AC:
5606
AN:
33346
South Asian (SAS)
AF:
0.0397
AC:
3014
AN:
75962
European-Finnish (FIN)
AF:
0.00349
AC:
144
AN:
41214
Middle Eastern (MID)
AF:
0.0216
AC:
88
AN:
4078
European-Non Finnish (NFE)
AF:
0.00872
AC:
9239
AN:
1059346
Other (OTH)
AF:
0.0251
AC:
1417
AN:
56450
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.430
Heterozygous variant carriers
0
1089
2179
3268
4358
5447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0286
AC:
4294
AN:
150174
Hom.:
129
Cov.:
0
AF XY:
0.0296
AC XY:
2172
AN XY:
73306
show subpopulations
African (AFR)
AF:
0.0507
AC:
2077
AN:
40974
American (AMR)
AF:
0.0221
AC:
335
AN:
15150
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
82
AN:
3456
East Asian (EAS)
AF:
0.170
AC:
858
AN:
5050
South Asian (SAS)
AF:
0.0481
AC:
229
AN:
4758
European-Finnish (FIN)
AF:
0.00295
AC:
30
AN:
10154
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
290
European-Non Finnish (NFE)
AF:
0.00919
AC:
619
AN:
67368
Other (OTH)
AF:
0.0294
AC:
61
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
201
401
602
802
1003
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00963
Hom.:
277

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 25, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gln51[15] in exon 1 of ASCL1: This variant is not expected to have clinical sign ificance because it has been reported in 19% (300/1604) of Japanese chromosomes (Ide 2005) and has been identified in 1.6% (5/304) of Caucasian control chromoso mes tested by our laboratory. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 14566559, 16021468, 20097173) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.22
Mutation Taster
=79/21
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3832799; hg19: chr12-103352171; COSMIC: COSV57151174; API